Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis
TH Open · 21.10.2026 · 10 (CP)
DOI: 10.1055/a-2976-7540 ↗Kurz gefasst
Fachartikel in der Zeitschrift TH Open, erschienen am 21.10.2026. Verfasst von Jurjen F Krommenhoek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thrombosis and HaemostasisLeiden University Medical CenterLeidenNetherlands. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Major bleeding frequently complicates the clinical course of left ventricular assist device (LVAD) therapy. However, data on recurrent major bleeding in destination therapy (DT) patients, as well as its impact on survival, are limited.
Methods
Single-center cohort of 122 predominantly DT LVAD between 2010 and 2024. A multistate model was estimated to evaluate first and recurrent major bleeding, and all-cause mortality. Patients who died within 14 days following implantation were excluded from the analysis.
Results
For the final analysis 116 patients (90 HeartWare HVAD; 26 HeartMate 3) were included; median age at implantation was 64 years (IQR 59–69 years); 80% were male and 56% had ischemic heart failure. During a follow-up period totaling 300 patient-years, 155 major bleeding episodes occurred in 60 patients. Half of the patients who experienced a first major bleeding (n = 60) went on to develop a subsequent recurrence (n = 30). Recurrence often occurred within a short interval after the initial major bleeding. Among these recurrences, 43% occurred at the same site as the initial major bleeding.
Conclusion
Following an initial major bleeding, LVAD patients frequently experienced either recurrent major bleeding or death within a short interval. The overall incidence of (recurrent) major bleeding was high. These findings highlight the burden of recurrent bleeding events and their impact on DT LVAD patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thrombosis and HaemostasisLeiden University Medical CenterLeidenNetherlands.
- Department of CardiologyLeiden University Medical CenterLeidenNetherlands.
- Department of Cardiothoracic SurgeryLeiden University Medical CenterLeidenNetherlands.
- Department of Clinical EpidemiologyLeiden University Medical CenterLeidenNetherlands.
- Department of Clinical Pharmacology and ToxicologyLeiden University Medical CenterLeidenNetherlands.
- Department of Biomedical Data ScienceLeiden University Medical CenterLeidenNetherlands.
ORCID-Profile: Jurjen F Krommenhoek, Sabine F B van der Horst, Frederikus A Klok
Zitieren
APA
Krommenhoek, J. F., Janssen, E., den Exter, P. L., van der Horst, S. F. B., Beeres, S. L. M. A., Hjortnaes, J., Palmen, M., Klok, F. A., van Rein, N., Fiocco, M., Jukema, W., & Tops, L. F. (2026). Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis. TH Open, 10(CP). https://doi.org/10.1055/a-2976-7540
Vancouver
Krommenhoek JF, Janssen E, den Exter PL, van der Horst SFB, Beeres SLMA, Hjortnaes J, et al. Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis. TH Open. 2026;10(CP). doi:10.1055/a-2976-7540
BibTeX
@article{Krommenhoek2026,
author = {Krommenhoek, Jurjen F and Janssen, Eva and den Exter, Paul L and van der Horst, Sabine F B and Beeres, Saskia L M A and Hjortnaes, Jesper and Palmen, Meindert and Klok, Frederikus A and van Rein, Nienke and Fiocco, Marta and Jukema, Wouter and Tops, Laurens F},
title = {Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis},
journal = {TH Open},
year = {2026},
volume = {10},
number = {CP},
doi = {10.1055/a-2976-7540}
}
EUVIMED